[Alterations in serum proteins in patients with hypernephroma (author's transl)].
D000230:Adenocarcinoma / Q000097:blood*; D000328:Adult; D000368:Aged; D000510:Alpha-Globulins / Q000032:analysis; D001609:Beta-Globulins / Q000032:analysis; D001797:Blood Protein Electrophoresis; D001798:Blood Proteins / Q000032:analysis*; D002570:Ceruloplasmin / Q000032:analysis; D005260:Female; D005326:Fetal Proteins / Q000032:analysis; D006242:Haptoglobins / Q000032:analysis; D006801:Humans; D005779:Immunodiffusion; D007136:Immunoglobulins / Q000032:analysis; D007680:Kidney Neoplasms / Q000097:blood*; D008074:Lipoproteins / Q000097:blood; D008259:Macroglobulins / Q000032:analysis; D008297:Male; D008875:Middle Aged; D012709:Serum Albumin / Q000032:analysis; D014168:Transferrin / Q000032:analysis; D000515:alpha 1-Antitrypsin / Q000097:blood
D000510:Alpha-Globulins; D001609:Beta-Globulins; D001798:Blood Proteins; D005326:Fetal Proteins; D006242:Haptoglobins; D007136:Immunoglobulins; D008074:Lipoproteins; D008259:Macroglobulins; D012709:Serum Albumin; D014168:Transferrin; D000515:alpha 1-Antitrypsin; D002570:Ceruloplasmin
Serumeiweissbild beim hypernephroiden Karzinom